An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ICU Medical, Inc. (Nasdaq:ICUI) announces the time of its second quarter 2023 earnings release and conference call, scheduled for August 7th, 2023. The call will be available by phone and webcast, with a replay option. Investors can access the call at (833) 816-1376, conference ID 10180958, or through the company's website at www.icumed.com.
Positive
None.
Negative
None.
SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call.
The Company will release its second quarter 2023 results on Monday, August 7th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, August 7th, 2023. The call can be accessed at (833) 816-1376, conference ID 10180958. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Brian Bonnell, Chief Financial Officer (949) 366-2183
ICR, Inc. John Mills, Managing Partner (646) 277-1254
Source: ICU Medical, Inc.
FAQ
What is the date of ICU Medical, Inc.'s second quarter 2023 earnings release?
ICU Medical, Inc.'s second quarter 2023 earnings release is scheduled for Monday, August 7th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT).
How can investors access the conference call?
Investors can access the conference call by dialing (833) 816-1376, conference ID 10180958, or through the company's website at www.icumed.com by clicking on the Investors tab, then the Webcast icon.
Will the conference call be available for replay?
Yes, the webcast of the conference call will be available for replay.
icu medical is in the business of making connections -- human connections. we design and make some of the world's safest, most reliable medical devices and systems for infusion therapy, oncology, and critical care applications. our products improve patient outcomes by helping prevent bloodstream infections and protecting patients and healthcare workers from exposure to infectious diseases or hazardous drugs. our complete product line includes needlefree vascular access devices, custom infusion systems, closed delivery systems for hazardous drugs, advanced sensor catheters and hemodynamic monitoring systems. together, we help forge the human and emotional connections that are a vital link between patients and caregivers, that enhance clinical experience, and are the essence of outstanding quality-of-care. icu medical is headquartered in san clemente, california.
